{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 0.98684114, "regularMarketPrice": 3.07, "exchange": "NMS", "shortName": "Xilio Therapeutics, Inc.", "longName": "Xilio Therapeutics, Inc.", "messageBoardId": "finmb_365333564", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1634909400000, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.029999971, "regularMarketTime": 1684179652, "regularMarketDayHigh": 3.13, "regularMarketDayRange": "3.0398 - 3.13", "regularMarketDayLow": 3.0398, "regularMarketVolume": 6825, "regularMarketPreviousClose": 3.04, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 18, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 3.11, "averageDailyVolume3Month": 28643, "averageDailyVolume10Day": 18810, "fiftyTwoWeekLowChange": 1.1199999, "fiftyTwoWeekLowChangePercent": 0.5743589, "fiftyTwoWeekRange": "1.95 - 4.92", "fiftyTwoWeekHighChange": -1.8500001, "fiftyTwoWeekHighChangePercent": -0.3760163, "fiftyTwoWeekLow": 1.95, "fiftyTwoWeekHigh": 4.92, "earningsTimestamp": 1683635400, "earningsTimestampStart": 1683635400, "earningsTimestampEnd": 1683635400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.19, "epsForward": -2.94, "epsCurrentYear": -2.75, "priceEpsCurrentYear": -1.1163636, "sharesOutstanding": 27470500, "bookValue": 3.852, "fiftyDayAverage": 3.07336, "fiftyDayAverageChange": -0.003360033, "fiftyDayAverageChangePercent": -0.0010932768, "twoHundredDayAverage": 2.7998, "twoHundredDayAverageChange": 0.2702, "twoHundredDayAverageChangePercent": 0.0965069, "marketCap": 85132632, "forwardPE": -1.0442176, "priceToBook": 0.79698855, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-22", "averageAnalystRating": "1.8 - Buy", "displayName": "Xilio Therapeutics", "symbol": "XLO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "828 Winter Street", "address2": "Suite 300", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 524 2466", "website": "https://xiliotx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Xilio Therapeutics, Inc., a clinical-stage biotechnology company, discovers and develops tumor-activated immuno-oncology therapies. Its checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 1 clinical trial for patients with advanced solid tumors. The company also develops cytokine programs, which comprises XTX202, a tumor-activated IL-2; and XTX301, an investigational tumor-activated, engineered IL-12 molecule. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 89, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rene  Russo BCPS, Pharm.D, Pharm.D.", "age": 47, "title": "CEO & Director", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 888493, "fmt": "888.49k", "longFmt": "888,493"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Martin H. Huber M.D.", "age": 61, "title": "Pres and Head of R&D", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 740010, "fmt": "740.01k", "longFmt": "740,010"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1025, "fmt": "1.02k", "longFmt": "1,025"}}, {"maxAge": 1, "name": "Mr. Kevin M. Brennan", "age": 52, "title": "Sr. VP of Fin. & Accounting and Director", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Uli  Bialucha Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christopher  Frankenfield", "title": "Chief Legal & Admin. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Julissa  Viana", "title": "VP of Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bill  Avery Ph.D.", "title": "Sr. VP of Nonclinical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Stacey J. Davis", "title": "Chief Bus. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}